- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 12, 2026 | 1.3B sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 1.3B sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 1.28B sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 1.25B sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 1.24B sh |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$2.6M |
| Operating Cash Flow restated | Q3 2026 · Mar 31, 2025 | −$2.59M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $2.13M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $1.02M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $38.01M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $37.37M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $875.42K |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $1.63M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $936.08K |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $1.73M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $3.12M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $3.29M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $38.94M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $39.1M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $814.9K |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $2.83M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $1.17M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $4.37M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$513.06K |
| Net Income | Q3 2026 · Mar 31, 2026 | −$2.36M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$1.15M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$3.49M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$709.99K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$2.83M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$1.22M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$4.45M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $163.91K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $168.64K |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $542 |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $69.39K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $296.09K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $298.31K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $155 |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $59.3K |
| Revenue | Q3 2026 · Mar 31, 2026 | $460.01K |
| Revenue | Q3 2026 · Mar 31, 2026 | $466.95K |
| Revenue | Q3 2026 · Mar 31, 2025 | $697 |
| Revenue | Q3 2026 · Mar 31, 2025 | $128.69K |
| Stock Issued | Q3 2026 · Jul 1, 2025 | 7.74M sh |
| Stock Issued | Q3 2026 · Feb 18, 2025 | 3.91M sh |
| Stock Issued | Q3 2026 · Jan 2, 2025 | 3.28M sh |
| Short Term Investments | Q3 2026 · Jun 30, 2025 | $1.28M |
| Stock Repurchased | Q3 2026 · Mar 31, 2025 | $65K |
| Capex | Q3 2026 · Mar 31, 2025 | $361 |